Sesen Bio Inc (SESN)

[the gipper]

Horses are restless this morning! Great news in preperatiion for the American Association of Cancer Research (AACR) Annual Meeting 2017 in Washington, D.C....Sure sounds like the data on " the active pharmaceutical ingredient used to formulate ViciniumTM and ProxiniumTM, and deBouganin, the de-immunized payload used in the Company’s systemically-administered drug candidates" could launch a huge run this week! The reach of these therapies is beyond significant. Will be an interestting week as we head to the AACR meeting!